OncoGenex Pharmaceuticals (OGXI)

Add to Watchlists Create an Alert
3.18 +0.08  +2.58% NASDAQ Jul 24, 8:00PM BATS Real time Currency in USD
View Full Chart
OGXI Price Chart
View All Events

OGXI Events

Date Type Description
04/30/2014 16:30 EDT Misc Q1 2014 OncoGenex Pharmaceuticals Inc Earnings Conference Call
04/30/2014 Earnings Q1 2014 OncoGenex Pharmaceuticals Inc Earnings Results. Estimate: -0.44.
03/11/2014 16:30 EDT Misc OncoGenex Pharmaceuticals, Inc. Q4 2013 Earning Conference Call
03/11/2014 Earnings OncoGenex Pharmaceuticals, Inc. Q4 2013 Earning Result. Estimate: -0.62.
11/07/2013 16:30 EDT Misc OncoGenex to Report Financial Results for Third Quarter Conference Call
11/07/2013 Earnings OncoGenex to Report Financial Results for Third Quarter 2013 and Address Key Questions From Investors on November 7, 2013. Estimate: -0.69.
08/08/2013 16:30 EDT Misc OncoGenex to Webcast Discussion of Clinical Development Program and Second Quarter 2013 Financial Results on August 8, 2013
08/08/2013 Earnings OncoGenex Announces Second Quarter 2013 Financial Results on August 8, 2013. Estimate: -0.63.
View All Performance Charts

OGXI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). OncoGenex Pharmaceuticals is down 68.20% over the last year vs S&P 500 Total Return up 20.39%, Merrimack Pharmaceuticals up 17.03%, and Acorda Therapeutics down 20.55%.

Get Quote for
Advertisement

Portfolio Strategies Featuring OGXI

Did OncoGenex Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

OGXI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.oncogenex.com
  • IR Website: http://ir.oncogenex.com/index.cfm
  • HQ Country: United States
  • HQ State/Province: Washington
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: In-Vitro Diagnostic Substance Manufacturing
  • NAICS Code: 325413
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

OncoGenex Pharmaceuticals Inc is a biopharmaceutical company engaged in the development & commercialization of therapies that address treatment resistance in cancer patients. It has three product candidates in pipeline: custirsen, apatorsen & OGX-225.

OGXI Excel Add-In Codes

  • Name: =YCI("OGXI","name")
  • Description: =YCI("OGXI","description")
  • Sector: =YCI("OGXI","sector")
  • Industry: =YCI("OGXI","industry")
  • Est. Current Fiscal Year End: =YCI("OGXI","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.